Depression Common Among Older Patients With Chronic Schizophrenia
Researchers investigated the influencing factors, prevalence, and cognitive characteristics of depressive symptoms in older patients with chronic schizophrenia.
Neurocognitive Disorders
Obesity With Cardiometabolic Abnormalities Tied to Cognitive Decline
Poorer cognitive trajectories seen for Hispanics/Latinos with central obesity in presence of cardiometabolic abnormalities
Certain Antihypertensive Agents May Aid Cognition in Older Patients
Memory recall better for up to 3 years with blood-brain barrier-crossing renin-angiotensin drugs vs nonpenetrant counterparts
Afternoon Napping Tied to Better Cognition in Older Adults
Afternoon napping is associated with better cognitive function in older adults, according to a study published in General Psychiatry.
Dancing, Stretching, and Anything but Sitting Still: Benefits of Exercise for Older Adults
Deborah Dunn, EdD, MSN, GNP-BC, ACNS-BC, GS-C, highlights recent findings that underscore the benefits of reducing sedentary time for older adults.
Rural Medicare Beneficiaries With AD Survive Less Than Urban Counterparts
Compared to urban counterparts, rural Medicare beneficiaries with Alzheimer Disease have shorter survival and spend more time in nursing homes.
Update on Alzheimer Dementia Spectrum: Diagnosis and Management
Although the cause of Alzheimer disease is not clear, recent advances in research have furthered the understanding of Alzheimer dementia as a continuum.
Insufficient and Excessive Sleep Associated With Faster Cognitive Decline
Both insufficient and excessive sleep are associated with faster cognitive decline compared with sleeping approximately 7 hours per night.
Adolescents Not Receiving Guidance From Primary Care Providers on Adult Health Care
Research conducted by the CDC concludes that the majority of adolescents, especially those aged 12 to 14 years, are not receiving comprehensive health care transition planning by their primary care provider.
Pimavanserin Effective for Depression in Parkinson Disease, Major Depressive Disorder
Researchers conducted an 8-week, open-label, single-arm study and a subsequent 2-stage, sequential, parallel comparison study to assess the use of pimavanserin among patients with Parkinson disease and major depressive disorder.
- Loading...
Loading...
Next post in Psych Congress 2020
Loading... 
Loading...